Divergent roles of macrophage subsets, FoxP3, and IL-17A in HSV-1-induced CNS pathology

Ujjaldeep Jaggi1, Satoshi Hirose1, Shaohui Wang1

  • 1Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, CSMC, Los Angeles, California, United States of America.

Plos Pathogens
|November 17, 2025
PubMed

Insights

Herpes simplex virus type 1 (HSV-1) infection outcomes in the central nervous system (CNS) depend on macrophage roles. Targeting M1 macrophages may prevent HSV-1-induced demyelination.

Area of Science:

  • Neuroimmunology
  • Virology
  • Pathology

Background:

  • Macrophages are key in neuroinflammation, with roles in antigen presentation and cytokine production.
  • Herpes simplex virus type 1 (HSV-1) infection can cause central nervous system (CNS) pathology.
  • While wild-type (WT) HSV-1 induces CNS demyelination dependent on macrophages, a recombinant HSV-1 expressing interleukin-2 (HSV-IL-2) causes pathology independently of macrophages.

Purpose of the Study:

  • To investigate the roles of IL-17A, FoxP3, and macrophages in HSV-1-induced CNS demyelination.
  • To determine the specific contributions of macrophage subsets (M1 and M2) in modulating demyelination.
  • To explore potential therapeutic strategies targeting macrophage activation for preventing CNS demyelination.

Main Methods:

  • Utilized two mouse models: one infected with HSV-IL-2 and another with WT HSV-1.
  • Employed genetic depletion strategies for FoxP3, macrophages, and combined macrophage/FoxP3 depletion.
  • Investigated demyelination in M1 and M2 macrophage knockout mice, as well as IL-17A-deficient mice.

Main Results:

  • Combined macrophage and FoxP3 depletion triggered demyelination in HSV-IL-2 infection but prevented it in WT HSV-1 infection.
  • Macrophage depletion alone in WT HSV-1 infection induced demyelination, highlighting their protective role.
  • M1 macrophages were identified as drivers of demyelination, while M2 macrophages appeared protective.
  • Absence of IL-17A with macrophage depletion was beneficial in HSV-IL-2 infection.

Conclusions:

  • FoxP3, IL-17A, and macrophage subsets play distinct, non-redundant roles in modulating CNS pathology during HSV-1 infection.
  • M1 macrophage activation is a critical factor in HSV-1-induced demyelination.
  • Targeting M1 macrophage activation presents a potential therapeutic strategy for limiting CNS demyelination.